Similar articles for PMID: 24637693

Year	Number of Results
1976	1
1977	1
1978	2
1979	1
1980	1
1981	1
1982	4
1983	2
1984	1
1985	1
1992	1
1997	2
1998	1
2000	1
2001	1
2002	3
2005	1
2007	2
2008	1
2009	1
2011	4
2012	3
2013	3
2014	6
2015	7
2016	7
2017	12
2018	15
2019	8
2020	10
2021	3
2022	1
2024	0

1

Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.

Blumenthal KG, Youngster I, Shenoy ES, Banerji A, Nelson SB. Blumenthal KG, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3137-43. doi: 10.1128/AAC.02504-13. Epub 2014 Mar 17. Antimicrob Agents Chemother. 2014. PMID: 24637693 Free PMC article.

2

Tolerability of Cefazolin in Nafcillin-Intolerant Patients for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infections.

Gandhi AM, Shah MD, Donohue LE, Cox HL, Eby JC. Gandhi AM, et al. Clin Infect Dis. 2021 Nov 2;73(9):1650-1655. doi: 10.1093/cid/ciab368. Clin Infect Dis. 2021. PMID: 33905485 Free PMC article.

3

Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.

Youngster I, Shenoy ES, Hooper DC, Nelson SB. Youngster I, et al. Clin Infect Dis. 2014 Aug 1;59(3):369-75. doi: 10.1093/cid/ciu301. Epub 2014 Apr 29. Clin Infect Dis. 2014. PMID: 24785233 Free PMC article.

4

Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.

Burrelli CC, Broadbent EK, Margulis A, Snyder GM, Gold HS, McCoy C, Mahoney MV, Hirsch EB. Burrelli CC, et al. Chemotherapy. 2018;63(6):345-351. doi: 10.1159/000499033. Epub 2019 Apr 9. Chemotherapy. 2018. PMID: 30965335

5

Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.

Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB; Korea INfectious Diseases (KIND) study group. Lee S, et al. Clin Microbiol Infect. 2018 Feb;24(2):152-158. doi: 10.1016/j.cmi.2017.07.001. Epub 2017 Jul 8. Clin Microbiol Infect. 2018. PMID: 28694202 Free article. Clinical Trial.

6

Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.

Pollett S, Baxi SM, Rutherford GW, Doernberg SB, Bacchetti P, Chambers HF. Pollett S, et al. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4684-9. doi: 10.1128/AAC.00243-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27216053 Free PMC article.

7

Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections.

Chan L, Chan-Tompkins NH, Como J, Guarascio AJ. Chan L, et al. Ann Pharmacother. 2020 Jul;54(7):662-668. doi: 10.1177/1060028019897267. Epub 2019 Dec 30. Ann Pharmacother. 2020. PMID: 31888347

8

A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.

Miller MA, Fish DN, Barber GR, Barron MA, Goolsby TA, Moine P, Mueller SW. Miller MA, et al. J Microbiol Immunol Infect. 2020 Apr;53(2):321-327. doi: 10.1016/j.jmii.2018.07.006. Epub 2018 Aug 18. J Microbiol Immunol Infect. 2020. PMID: 30190234 Free article.

9

Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Twilla JD, Algrim A, Adams EH, Samarin M, Cummings C, Finch CK. Twilla JD, et al. Am J Med Sci. 2020 Jul;360(1):35-41. doi: 10.1016/j.amjms.2020.04.006. Epub 2020 Apr 17. Am J Med Sci. 2020. PMID: 32376001

10

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN. Schweizer ML, et al. BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279. BMC Infect Dis. 2011. PMID: 22011388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year